LSL Pharma Group Announces Brokered Private Placement of Convertible Debentures of Up to $4,000,000
Debenture proceeds will provide additional funds and flexibility for growth BOUCHERVILLE, Québec, Sept. 21, 2023…
Year: 2023
CentralReach Launches Scientific Advisory Board to Provide Strategic Guidance on the Autism and IDD Care Industry
Six members join the advisory board to provide insights and advice on the present and…
CentralReach Launches Scientific Advisory Board to Provide Strategic Guidance on the Autism and IDD Care Industry
Six members join the advisory board to provide insights and advice on the present and…
Farlight Games Reveals Casual Open-World RPG AFK Journey, A New Game in the AFK Series, is Available Now in Limited Closed Beta
Bring Your Favorite Characters from AFK Arena on a Brand New Casual Open-World Adventure SHANGHAI,…
Farlight Games Reveals Casual Open-World RPG AFK Journey, A New Game in the AFK Series, is Available Now in Limited Closed Beta
Bring Your Favorite Characters from AFK Arena on a Brand New Casual Open-World Adventure SHANGHAI,…
PHANTOM GALAXIES™ brings AAA multiplayer mecha action-RPG to Steam and Epic Games Store on 2 November 2023
Animoca Brands’ subsidiary Blowfish Studios will launch the game in free-to-play early access SYDNEY, Australia,…
Victory Real Estate Group Celebrating 15 Years of Impacting Communities Through Superior Commercial Real Estate Development
At Victory Real Estate Group, they believe in building strong sustainable communities that prioritize social…
Food and Ag Leader Kevin Burkum named CEO of U.S. Farmers & Ranchers in Action
Burkum, an experienced agricultural advocate, is set to lead USFRA into a new era that…
ISA Underscores Importance of People to Automation in New Position Paper
Automation does not eliminate jobs, rather it repurposes existing jobs and creates new ones. New position…
Cognetivity Neurosciences Partners with No Fear Counselling to Pioneer Brain Health Assessment Through Groundbreaking AI Technology
New Approach to Measuring Impact of Counselling to Deliver Next Generation Care to Mental Health…
Introducing CleverAutomations: Ready-to-Use Automation Journeys for Recurring Revenue Growth
COLOGNE, GERMANY / ACN Newswire / September 21, 2023 / Cleverbridge, a growth engine for…
Hong Kong Dinner in London returns after 4-year hiatus
London, Sept 21, 2023 – (ACN Newswire) – After a four-year absence due to the…
Hired’s 2023 State of Tech Salaries Report Reveals US Inflation-Adjusted Salaries Plummet to a Five-Year Low
Report shows jobseekers are adjusting preferences, economic conditions and the introduction of Generative AI threaten…
Metronet Names New CEO, CFO
Company Executes Succession Plan; Prepares for Future Growth EVANSVILLE, Ind.–(BUSINESS WIRE)–Metronet announced today the advancement…
U.S. Firms Embrace Providers of Contact Center Automation
Partner engagements are increasing as enterprises aggressively adopt AI, analytics, cloud migration, ISG Provider Lens™…
Bullhorn Promotes Jonathan Bedard to Chief Marketing Officer
Internal promotion to top marketing role will help company continue to grow and deliver an…
U.S. Food and Drug Administration Approves Orphan Drug Designation for Nexcella NXC-201 as a Treatment for Amyloid Light Chain (AL) Amyloidosis
FDA Orphan Drug Designation (“ODD”) qualifies one-time treatment NXC-201 for: 7 years of U.S. market…
U.S. Food and Drug Administration Approves Orphan Drug Designation for Nexcella NXC-201 as a Treatment for Amyloid Light Chain (AL) Amyloidosis
FDA Orphan Drug Designation (“ODD”) qualifies one-time treatment NXC-201 for: 7 years of U.S. market…
Krystal Biotech Announces FDA Clearance of Investigational New Drug Application for KB408 for the Treatment of Type 1 Alpha-1 Antitrypsin Deficiency
• Orphan Drug Designation Granted to KB408 PITTSBURGH, Sept. 21, 2023 (GLOBE NEWSWIRE) — Krystal…
Krystal Biotech Announces FDA Clearance of Investigational New Drug Application for KB408 for the Treatment of Type 1 Alpha-1 Antitrypsin Deficiency
• Orphan Drug Designation Granted to KB408 PITTSBURGH, Sept. 21, 2023 (GLOBE NEWSWIRE) — Krystal…